Logo for Crescita Therapeutics Inc

Crescita Therapeutics Investor Relations Material

Latest events

Logo for Crescita Therapeutics

Q3 2024

5 Nov, 2024
Logo for Crescita Therapeutics

Q2 2024

5 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Crescita Therapeutics Inc

Access all reports
Crescita Therapeutics Inc. is a Canadian company engaged in the commercial dermatology sector. It specializes in both prescription and non-prescription skincare products aimed at treating various skin conditions and diseases. Crescita's product portfolio includes a notable prescription product, Pliaglis, which utilizes a proprietary phase-changing cream technology and is available in over 40 countries. The company is headquartered in Laval, Quebec, and its shares are listed on the Toronto Stock Exchange.